- Home
- MTRN vs ARWR Comparison
MTRN vs ARWR Comparison
Compare MTRN & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTRN
- ARWR
- Stock Information
- Founded
- MTRN 1931
- ARWR 2003
- Country
- MTRN United States
- ARWR United States
- Employees
- MTRN N/A
- ARWR N/A
- Industry
- MTRN Industrial Specialties
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- MTRN Industrials
- ARWR Health Care
- Exchange
- MTRN Nasdaq
- ARWR Nasdaq
- Market Cap
- MTRN 2.4B
- ARWR 2.4B
- IPO Year
- MTRN N/A
- ARWR 1993
- Fundamental
- Price
- MTRN $100.43
- ARWR $19.59
- Analyst Decision
- MTRN Strong Buy
- ARWR Buy
- Analyst Count
- MTRN 2
- ARWR 12
- Target Price
- MTRN $143.50
- ARWR $42.70
- AVG Volume (30 Days)
- MTRN 108.4K
- ARWR 2.2M
- Earning Date
- MTRN 02-13-2025
- ARWR 02-04-2025
- Dividend Yield
- MTRN 0.53%
- ARWR N/A
- EPS Growth
- MTRN N/A
- ARWR N/A
- EPS
- MTRN 3.54
- ARWR N/A
- Revenue
- MTRN $1,668,911,000.00
- ARWR $3,551,000.00
- Revenue This Year
- MTRN $3.05
- ARWR $4,919.71
- Revenue Next Year
- MTRN $6.29
- ARWR $56.14
- P/E Ratio
- MTRN $28.58
- ARWR N/A
- Revenue Growth
- MTRN N/A
- ARWR N/A
- 52 Week Low
- MTRN $96.18
- ARWR $17.05
- 52 Week High
- MTRN $145.08
- ARWR $39.83
- Technical
- Relative Strength Index (RSI)
- MTRN 32.70
- ARWR 39.27
- Support Level
- MTRN $98.50
- ARWR $19.10
- Resistance Level
- MTRN $101.52
- ARWR $22.47
- Average True Range (ATR)
- MTRN 3.02
- ARWR 1.05
- MACD
- MTRN -1.29
- ARWR -0.48
- Stochastic Oscillator
- MTRN 10.12
- ARWR 4.56
About MTRN Materion Corporation
Materion Corp is a producer of engineered materials based in the United States. The company produces materials used in electrical, electronic, thermal, and structural applications. The company operates in four reportable segments: Performance Materials, Electronic Materials, Precision Optics, and Other. The majority of revenue is derived from Electronic Materials which produces chemicals, microelectronics packaging, precious metal, non-precious metal, and specialty metal products, including vapor deposition targets, frame lid assemblies, clad and precious metal pre-forms, high temperature braze materials, and ultra-pure wire.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.